Product Program year 2025 Source: CMS Open Payments

Claria MRI Quad CRT-D Surescan

Device Cardiac Resynchronization Therapy - CRT

PDI 00763000059514

Open in the dashboard

General payments

$54,673

1,114 payments

Research payments

$0

0 payments

Through program year 2025, $54,673 in general payments and $0 in research payments were reported against Claria MRI Quad CRT-D Surescan (Cardiac Resynchronization Therapy - CRT).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $610 21
2024 General $6,671 113
2023 General $20,874 414
2022 General $26,518 566

Breakdown

Who paid General payments · program years 2022–2025
  1. Medtronic, Inc. $54,673 1,114 payments
Top recipients General payments · program year 2025
  1. Eric Taylor Clinical Cardiac Electrophysiology · McAllen, TX $260 43% · 6 payments
  2. Mazhar Khan Clinical Cardiac Electrophysiology · McAllen, TX $173 28% · 1 payment
  3. Francisco Perez Clinical Cardiac Electrophysiology · Ponce, PR $28 5% · 1 payment
  4. Patricia Chavarria Nurse Practitioner, Family · South Miami, FL $19 3% · 1 payment
  5. Subbarao Yarra Cardiovascular Disease · McAllen, TX $18 3% · 2 payments

The top 5 of 15 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Clinical Cardiac Electrophysiology Internal Medicine $518 86% · 8 practitioners
  2. Cardiovascular Disease Internal Medicine $38 6% · 3 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $19 3% · 1 practitioner
  4. Public Health & General Preventive Medicine Preventive Medicine $17 3% · 1 practitioner
  5. Pediatric Cardiology Pediatrics $13 2% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Texas $283 46% · 3 recipients
  2. Michigan $173 28% · 1 recipient
  3. Florida $74 12% · 6 recipients
  4. Puerto Rico $66 11% · 4 recipients
  5. Ohio $13 2% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

1,114 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record